{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:31:14Z","timestamp":1793964674609,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.prp.2025.156040","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T06:40:11Z","timestamp":1748328011000},"page":"156040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Gleason score down and upgrading at radical prostatectomy in targeted vs. systematic prostate biopsy: Findings from an institutional cohort"],"prefix":"10.1016","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-1761","authenticated-orcid":false,"given":"Vincenzo","family":"Fiorentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Zuccal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pizzimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Curduman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156040_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal versus transrectal magnetic resonance imaging\u2013targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.euo.2023.04.004","article-title":"Impact of magnetic resonance imaging targeting on pathologic upgrading and downgrading at prostatectomy: a systematic review and meta-analysis","volume":"6","author":"Weinstein","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.prp.2025.156040_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2025.156040_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/his.14113","article-title":"MRI-targeted prostate biopsy: key considerations for pathologists","volume":"77","author":"Gordetsky","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156040_bib7","first-page":"2493","article-title":"Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery","volume":"38","author":"Ploussard","year":"2020"},{"key":"10.1016\/j.prp.2025.156040_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00345-024-04963-w","article-title":"The impact of MpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology","volume":"42","author":"Sorce","year":"2024","journal-title":"World J. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eururo.2024.02.003","article-title":"Does overgrading on targeted biopsy of magnetic resonance imaging-visible lesions in prostate cancer lead to overtreatment?","volume":"86","author":"Baboudjian","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2021.06.026","article-title":"Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer","volume":"80","author":"Vickers","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","article-title":"Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified gleason grading system and factoring in tertiary grades","volume":"61","author":"Epstein","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/JU.0000000000001074","article-title":"Downgrading from biopsy grade group 4 prostate cancer in patients undergoing radical prostatectomy for high or very high risk prostate cancer","volume":"204","author":"Ranasinghe","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.urology.2019.11.016","article-title":"How many cores should be obtained during saturation biopsy in the era of multiparametric magnetic resonance? Experience in 875 patients submitted to repeat prostate biopsy","volume":"137","author":"Pepe","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.prp.2025.156040_bib14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.urology.2008.05.045","article-title":"Is Quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?","volume":"72","author":"Pepe","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.prp.2025.156040_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/diagnostics11010010","article-title":"Histopathological ratios to predict gleason score agreement between biopsy and radical prostatectomy","volume":"11","author":"Fiorentino","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.prp.2025.156040_bib16","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2025.156040_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer\u20142020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.21873\/invivo.11075","article-title":"Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer","volume":"31","author":"PEPE","year":"2017","journal-title":"Vivo (Brooklyn)"},{"key":"10.1016\/j.prp.2025.156040_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.21873\/anticanres.11333","article-title":"Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights","volume":"37","author":"FANDELLA","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prp.2025.156040_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1c) Prostate Cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2025.156040_bib21","article-title":"Routine Systematic Prostate Biopsies Not Replaced by Magnetic Resonance Imaging-Targeted Biopsy","volume":"74","author":"G\u00f3mez-Ortiz","year":"2022","journal-title":"Rev. Investig. Clin."},{"key":"10.1016\/j.prp.2025.156040_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.urology.2014.03.037","article-title":"Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer","volume":"84","author":"Kozminski","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.prp.2025.156040_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eururo.2015.03.044","article-title":"Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes","volume":"69","author":"Imnadze","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.urology.2021.05.028","article-title":"Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations","volume":"155","author":"Hesterberg","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.prp.2025.156040_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2020.02.004","article-title":"Gleason Pattern 4 with Cribriform Morphology on Biopsy Is Associated with Adverse Clinicopathological Findings in a Prospective Radical Prostatectomy Cohort","volume":"98","author":"Haffner","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2025.156040_bib26","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/cancers15051372","article-title":"Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes\u2014Systematic Review and Meta-Analysis","volume":"15","author":"Osiecki","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2025.156040_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.euf.2023.08.010","article-title":"Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer","volume":"10","author":"Bernardino","year":"2024","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.prp.2025.156040_bib28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/his.13893","article-title":"Concordance of Cribriform Architecture in Matched Prostate Cancer Biopsy and Radical Prostatectomy Specimens","volume":"75","author":"Hollemans","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156040_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/JU.0000000000000526","article-title":"Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance","volume":"203","author":"Ericson","year":"2020","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/his.13747","article-title":"Concordance of Biopsy and Prostatectomy Diagnosis of Intraductal and Cribriform Carcinoma in a Prospectively Collected Data Set","volume":"74","author":"Masoomian","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156040_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-Specific Survival of Patients with Invasive Cribriform and Intraductal Prostate Cancer at Diagnostic Biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2025.156040_bib32","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic Impact of Intraductal Carcinoma and Large Cribriform Carcinoma Architecture after Prostatectomy in a Contemporary Cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2025.156040_bib33","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0000000000000691","article-title":"Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy","volume":"40","author":"Choy","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2025.156040_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital Quantification of Five High-Grade Prostate Cancer Patterns, Including the Cribriform Pattern, and Their Association With Adverse Outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2025.156040_bib35","article-title":"The Presence of Cribriform Pattern in Prostate Biopsy and Radical Prostatectomy Is Associated with Negative Postoperative Pathological Features","author":"Osiecki","year":"2024","journal-title":"Cent. Eur. J. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.juro.2018.01.081","article-title":"Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma","volume":"200","author":"Prendeville","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib37","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231948","article-title":"Comparison of Multiparametric MRI\u2013Targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer","volume":"312","author":"Ghai","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.prp.2025.156040_bib38","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.21873\/anticanres.15785","article-title":"Detection Rate of 68 Ga-PSMA PET\/CT vs. MpMRI Targeted Biopsy for Clinically Significant Prostate Cancer","volume":"42","author":"PEPE","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prp.2025.156040_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4081\/aiua.2022.3.274","article-title":"Targeted Prostate Biopsy: 68Ga-PSMA PET\/CT vs. MpMRI in the Diagnosis of Prostate Cancer","volume":"94","author":"Pepe","year":"2022","journal-title":"Arch. Ital. di Urol. e Androl."},{"key":"10.1016\/j.prp.2025.156040_bib40","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.21873\/invivo.13211","article-title":"68 Ga-PSMA PET\/CT and Prostate Cancer Diagnosis: Which SUVmax Value?","volume":"37","author":"PEPE","year":"2023","journal-title":"Vivo (Brooklyn)"},{"key":"10.1016\/j.prp.2025.156040_bib41","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.3390\/jcm11123473","article-title":"Could 68Ga-PSMA PET\/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?","volume":"11","author":"Pepe","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2025.156040_bib42","doi-asserted-by":"crossref","DOI":"10.4081\/aiua.2023.11322","article-title":"68Ga-PSMA PET\/CT Evaluation in Men Enrolled in Prostate Cancer Active Surveillance","author":"Pepe","year":"2023","journal-title":"Arch. Ital. di Urol. e Androl."},{"key":"10.1016\/j.prp.2025.156040_bib43","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.21873\/anticanres.15621","article-title":"Should 68Ga-PSMA PET\/CT Replace CT and Bone Scan in Clinical Staging of High-Risk Prostate Cancer?","volume":"42","author":"PEPE","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prp.2025.156040_bib44","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.21873\/invivo.13769","article-title":"PSMA PET\/CT Accuracy in Diagnosing Prostate Cancer Nodes Metastases","volume":"38","author":"PEPE","year":"2024","journal-title":"Vivo (Brooklyn)"},{"key":"10.1016\/j.prp.2025.156040_bib45","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.3390\/curroncol31090383","article-title":"Role of Systematic Biopsy in the Era of Targeted Biopsy: A Review","volume":"31","author":"Malewski","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.prp.2025.156040_bib46","doi-asserted-by":"crossref","DOI":"10.4081\/aiua.2024.12992","article-title":"Multiparametric MRI Targeted Prostate Biopsy: When Omit Systematic Biopsy?","author":"Pepe","year":"2024","journal-title":"Arch. Ital. di Urol. e Androl."},{"issue":"22","key":"10.1016\/j.prp.2025.156040_bib47","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1002\/cncr.26169","article-title":"The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy","volume":"117","author":"Cooperberg","year":"2011","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.prp.2025.156040_bib48","first-page":"1288","article-title":"NCCN Guidelines\u00ae Insights: Prostate Cancer, Version 1.2023","volume":"20","author":"Schaeffer","year":"2022","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.prp.2025.156040_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eururo.2020.10.033","article-title":"A Comparison of Genitourinary Society Pathology and International Society of Urological Pathology Prostate Cancer Guidelines","volume":"79","author":"Epstein","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.156040_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12935-024-03231-6","article-title":"Targeting of H19\/Cell Adhesion Molecules Circuitry by GSK-J4 Epidrug Inhibits Metastatic Progression in Prostate Cancer","volume":"24","author":"Pecci","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.prp.2025.156040_bib51","article-title":"PD-L1 Expression in Prostate Cancer and Gleason Grade Group: Is There Any Relationship? Findings from a Multi-Institutional Cohort","volume":"269","author":"Fiorentino","year":"2025","journal-title":"Pathol. - Res. Pr."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T02:30:48Z","timestamp":1749004248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382500233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"alternative-id":["S034403382500233X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156040","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gleason score down and upgrading at radical prostatectomy in targeted vs. systematic prostate biopsy: Findings from an institutional cohort","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156040"}}